NCT06643702 Prevalence av BPPV Among Elderly in Primary Care
| NCT ID | NCT06643702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Stockholm |
| Condition | Benign Paroxysmal Positional Vertigo (BPPV) |
| Study Type | OBSERVATIONAL |
| Enrollment | 115 participants |
| Start Date | 2024-10-16 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 115 participants in total. It began in 2024-10-16 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate whether positional tests should be routinely performed on all elderly patients (65 years and older) presenting to primary care with symptoms of acute, episodic, or chronic dizziness or vertigo, unsteadiness, imbalance, and/or an increased tendency to fall in the past 12 months. Study aims to investigate whether diagnostic maneuvers should be performed regardless of the presence of conventional positional vertigo presentation associated with classical cases of benign paroxysmal positional vertigo (BPPV). Specifically, the study aims to identify "hidden" cases of BPPV and assess the potential benefits of clinical screening and initial treatment of BPPV in primary care setting thus improving the BPPV-related quality of life and reducing the risk of falls in the elderly population.
Eligibility Criteria
Inclusion Criteria: Patients aged 65 years or older and present to the primary care clinic with one or several of the following: 1. Acute, episodic, or chronic sensation of dizziness/vertigo. 2. Subjective or objective imbalance during stance or movements. 3. Presented with increased tendency of falls by exhibiting unintentional loss of balance resulting in a fall one or more times in the past 12 months. Exclusion Criteria: 1. Patients not meeting the above epidemiological and medical criteria described under "Inclusion Criteria". 2. Patients presenting with pathologies in which head and neck movements/manipulations are contraindicated, including (but not limited to): cervical instability, acute head and neck trauma, known cervical disk prolapse, Arnold-Chiari malformation, vascular pathologies such as carotid sinus syncope, vascular dissection and vertebrobasilarinsufficiency, including patients with paralysis as well as those with reduced mobility, in whom diagnostic maneuvers cannot be correctly performed.
Contact & Investigator
Luca Verrecchia, PhD
STUDY DIRECTOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT06643702 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Benign Paroxysmal Positional Vertigo (BPPV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06643702 currently recruiting?
Yes, NCT06643702 is actively recruiting participants. Contact the research team at emilija.rackauskaite@regionstockholm.se for enrollment information.
Where is the NCT06643702 trial being conducted?
This trial is being conducted at Saltsjö-Boo, Sweden.
Who is sponsoring the NCT06643702 clinical trial?
NCT06643702 is sponsored by Region Stockholm. The principal investigator is Luca Verrecchia, PhD at Karolinska Institutet. The trial plans to enroll 115 participants.